MOACM
FLGT icon

Mutual of America Capital Management’s Fulgent Genetics FLGT Stock Holding History

Mutual of America Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,033
Closed -$154K – 1501
2022
Q3 		$154K Buy
4,033
+722
+22% +$36.2K ﹤0.01% 1432
2022
Q2 		$181K Buy
3,311
+518
+19% +$28.5K ﹤0.01% 1364
2022
Q1 		$174K Buy
2,793
+144
+5% +$9.48K ﹤0.01% 1388
2021
Q4 		$266K Buy
2,649
+91
+4% +$8K ﹤0.01% 1270
2021
Q3 		$230K Buy
2,558
+43
+2% +$3.91K ﹤0.01% 1309
2021
Q2 		$232K Buy
2,515
+162
+7% +$12.9K ﹤0.01% 1343
2021
Q1 		$227K Buy
2,353
+687
+41% +$70.9K ﹤0.01% 1325
2020
Q4 		$87K Buy
1,666
+245
+17% +$10.2K ﹤0.01% 1513
2020
Q3 		$57K Buy
+1,421
New +$44.5K ﹤0.01% 1529

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mutual of America Capital Management's FLGT Position: Q4 2022 in Review

Mutual of America Capital Management sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 4,033 shares — an estimated $154K sold.

Mutual of America Capital Management first reported a position in FLGT in Q3 2020 and held it in 9 quarters. The position peaked at $266K in Q4 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Mutual of America Capital Management reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 4,033 Fulgent Genetics shares in Q4 2022, an estimated $154K.
  • Mutual of America Capital Management first reported a position in Fulgent Genetics in Q3 2020 and held it in 9 quarters.
  • Mutual of America Capital Management's Fulgent Genetics position peaked at $266K in Q4 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.